|
GPR137C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.345500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.045000E-01 |
| Normal-vs-Stage2 |
9.858200E-01 |
| Normal-vs-Stage3 |
2.280100E-02 |
| Normal-vs-Stage4 |
4.880400E-01 |
| Stage1-vs-Stage2 |
6.144000E-01 |
| Stage1-vs-Stage3 |
5.085900E-02 |
| Stage1-vs-Stage4 |
5.861800E-01 |
| Stage2-vs-Stage3 |
3.491800E-02 |
| Stage2-vs-Stage4 |
5.148200E-01 |
| Stage3-vs-Stage4 |
3.908400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.573900E-02 |
| Normal-vs-AfricanAmerican |
1.477820E-01 |
| Normal-vs-Asian |
4.941800E-02 |
| Caucasian-vs-AfricanAmerican |
9.975800E-01 |
| Caucasian-vs-Asian |
6.864200E-01 |
| AfricanAmerican-vs-Asian |
6.568200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.061000E-01 |
| Normal-vs-Female |
5.677800E-03 |
| Male-vs-Female |
3.225600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.384600E-01 |
| Normal-vs-Extreme_Weight |
7.021200E-01 |
| Normal-vs-Obese |
2.021900E-02 |
| Normal-vs-Extreme_Obese |
1.958180E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.067000E-01 |
| Normal_Weight-vs-Obese |
7.346600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.987900E-02 |
| Extreme_Weight-vs-Obese |
4.314000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.227600E-01 |
| Obese-vs-Extreme_Obese |
1.085620E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.764300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.257350E-03 |
| Normal-vs-Age(61-80Yrs) |
6.581200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.133960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.697800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.150300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.578230E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.416500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.644900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.882000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.005700E-02 |
| Normal-VS-Type2 PRCC |
3.652600E-01 |
| Normal-VS-KIRP CIMP |
1.368610E-01 |
| Normal-VS-Unclassified PRCC |
2.082800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.867800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.948010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.834200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.775800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.955200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.788400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.293200E-01 |
| Normal-vs-N1 |
5.716700E-03 |
| Normal-vs-N2 |
2.991600E-01 |
| N0-vs-N1 |
1.205830E-02 |
| N0-vs-N2 |
3.704400E-01 |
| N1-vs-N2 |
5.036000E-01 |
|
|
